Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2025 Earnings Call Transcript February 26, 2026
Collegium Pharmaceutical, Inc. misses on earnings expectations. Reported EPS is $0.4273 EPS, expectations were $2.19.
Operator: Greetings! Welcome to the Collegium Pharmaceutical, Inc. fourth quarter and full year 2025 earnings conference call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require...
